These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 33705873)

  • 1. Novel formulations and drug delivery systems to administer biological solids.
    Zhang Y; Davis DA; AboulFotouh K; Wang J; Williams D; Bhambhani A; Zakrewsky M; Maniruzzaman M; Cui Z; Williams RO
    Adv Drug Deliv Rev; 2021 May; 172():183-210. PubMed ID: 33705873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term delivery of protein therapeutics.
    Vaishya R; Khurana V; Patel S; Mitra AK
    Expert Opin Drug Deliv; 2015 Mar; 12(3):415-40. PubMed ID: 25251334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges in the delivery of peptide drugs: an industry perspective.
    Lewis AL; Richard J
    Ther Deliv; 2015 Feb; 6(2):149-63. PubMed ID: 25690084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanotechnologies for the delivery of biologicals: Historical perspective and current landscape.
    Durán-Lobato M; López-Estévez AM; Cordeiro AS; Dacoba TG; Crecente-Campo J; Torres D; Alonso MJ
    Adv Drug Deliv Rev; 2021 Sep; 176():113899. PubMed ID: 34314784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding molecular mechanisms of biologics drug delivery and stability from NMR spectroscopy.
    Phyo P; Zhao X; Templeton AC; Xu W; Cheung JK; Su Y
    Adv Drug Deliv Rev; 2021 Jul; 174():1-29. PubMed ID: 33609600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review on parenteral delivery of peptides and proteins.
    Jain D; Mahammad SS; Singh PP; Kodipyaka R
    Drug Dev Ind Pharm; 2019 Sep; 45(9):1403-1420. PubMed ID: 31215293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent developments in protein and peptide parenteral delivery approaches.
    Patel A; Cholkar K; Mitra AK
    Ther Deliv; 2014 Mar; 5(3):337-65. PubMed ID: 24592957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physicochemical and formulation developability assessment for therapeutic peptide delivery--a primer.
    Bak A; Leung D; Barrett SE; Forster S; Minnihan EC; Leithead AW; Cunningham J; Toussaint N; Crocker LS
    AAPS J; 2015 Jan; 17(1):144-55. PubMed ID: 25398427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic delivery of peptides by the oral route: Formulation and medicinal chemistry approaches.
    Brayden DJ; Hill TA; Fairlie DP; Maher S; Mrsny RJ
    Adv Drug Deliv Rev; 2020; 157():2-36. PubMed ID: 32479930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmaceutical protein solids: Drying technology, solid-state characterization and stability.
    Chen Y; Mutukuri TT; Wilson NE; Zhou QT
    Adv Drug Deliv Rev; 2021 May; 172():211-233. PubMed ID: 33705880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges for the pharmaceutical technical development of protein coformulations.
    Mueller C; Altenburger U; Mohl S
    J Pharm Pharmacol; 2018 May; 70(5):666-674. PubMed ID: 28470967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stabilization challenges and formulation strategies associated with oral biologic drug delivery systems.
    Truong-Le V; Lovalenti PM; Abdul-Fattah AM
    Adv Drug Deliv Rev; 2015 Oct; 93():95-108. PubMed ID: 26277263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in oral delivery of peptide hormones.
    Varamini P; Toth I
    Expert Opin Drug Deliv; 2016; 13(4):507-22. PubMed ID: 26787260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospects of formulating proteins/peptides as aerosols for pulmonary drug delivery.
    Shoyele SA; Slowey A
    Int J Pharm; 2006 May; 314(1):1-8. PubMed ID: 16563674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PEG-modified biopharmaceuticals.
    Bailon P; Won CY
    Expert Opin Drug Deliv; 2009 Jan; 6(1):1-16. PubMed ID: 19236204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of lipidation in the development of advanced protein and peptide therapeutics.
    Menacho-Melgar R; Decker JS; Hennigan JN; Lynch MD
    J Control Release; 2019 Feb; 295():1-12. PubMed ID: 30579981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of particulate drug delivery systems for oral delivery of Peptide and protein drugs.
    Christophersen PC; Fano M; Saaby L; Yang M; Nielsen HM; Mu H
    Curr Pharm Des; 2015; 21(19):2611-28. PubMed ID: 25876916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation and Delivery of Macromolecules.
    Morales JO
    AAPS PharmSciTech; 2017 Jan; 18(1):1-2. PubMed ID: 27943123
    [No Abstract]   [Full Text] [Related]  

  • 19. Dosing considerations for inhaled biologics.
    Ferrati S; Wu T; Kanapuram SR; Smyth HDC
    Int J Pharm; 2018 Oct; 549(1-2):58-66. PubMed ID: 30053488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical considerations in the formulation development of parenteral biologic drugs.
    Muralidhara BK; Wong M
    Drug Discov Today; 2020 Mar; 25(3):574-581. PubMed ID: 31926137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.